Primary prophylaxis with G-CSF may improve outcomes in patients with newly diagnosed stage III/IV Hodgkin lymphoma treated with brentuximab vedotin plus chemotherapy

A tétel rövid nézete
dc.contributor.authorStraus, David J.
dc.contributor.authorCollins, Graham
dc.contributor.authorWalewski, Jan
dc.contributor.authorZinzani, Pier Luigi
dc.contributor.authorGrigg, Andrew
dc.contributor.authorSureda, Anna
dc.contributor.authorIllés, Árpád
dc.contributor.authorKim, Tae Min
dc.contributor.authorAlekseev, Sergey
dc.contributor.authorSpecht, Lena
dc.contributor.authorBuccheri, Valeria
dc.contributor.authorYounes, Anas
dc.contributor.authorConnors, Joseph M.
dc.contributor.authorForero-Torres, Andres
dc.contributor.authorFenton, Keenan
dc.contributor.authorGautam, Ashish
dc.contributor.authorPurevjal, Indra
dc.contributor.authorLiu, Rachael
dc.contributor.authorGallamini, Andrea
dc.date.accessioned2020-08-26T11:19:08Z
dc.date.available2020-08-26T11:19:08Z
dc.date.issued2020
dc.date.oa2020-08-27
dc.date.pasync2020-12-11T01:30:16Z
dc.date.updated2020-12-11T01:30:16Z
dc.description.correctorLB
dc.identifier.citationLeukemia & Lymphoma. -61 : 12 (2020), p. 2931-2938. -Leuk. Lymphoma. - 1042-8194. - 1029-2403
dc.identifier.doihttp://dx.doi.org/10.1080/10428194.2020.1791846
dc.identifier.issn1029-2403
dc.identifier.issn1042-8194
dc.identifier.opachttp://webpac.lib.unideb.hu:8082/ebib/CorvinaWeb?action=cclfind&resultview=long&ccltext=idno+BIBFORM087548
dc.identifier.urihttp://hdl.handle.net/2437/291762
dc.identifier.urlhttps://www.tandfonline.com/doi/full/10.1080/10428194.2020.1791846
dc.languageeng
dc.rights.accessopen access article
dc.subject.mabOrvostudományok
dc.subject.mabKlinikai orvostudományok
dc.titlePrimary prophylaxis with G-CSF may improve outcomes in patients with newly diagnosed stage III/IV Hodgkin lymphoma treated with brentuximab vedotin plus chemotherapy
dc.typeidegen nyelvű folyóiratközlemény külföldi lapban
Fájlok
Eredeti köteg (ORIGINAL bundle)
Megjelenítve 1 - 1 (Összesen 1)
Nincs kép
Név:
Primary_prophylaxis_with_G_CSF_may_improve_outcomes_in_patients_with_newly_diagnosed_stage_III_IV_Hodgkin_lymphoma_treated_with_brentuximab_vedotin.pdf
Méret:
1.27 MB
Formátum:
Adobe Portable Document Format
Leírás:
kiadói változat
Letöltés
Gyűjtemények
Publikációs Adatbázis